Christine Rizzo

Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the <i>B-Raf</i> V600E Mutation

Huisheng Wang, Sherif Daouti, Wenhui Li et al. · Cancer Research · 2011 · 74 citations

Medicine, Oncology, Pharmacology +17

High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097

Wei He, Leopoldo Luistro, Daisy Carvajal et al. · Molecular Oncology · 2011 · 55 citations · Full text

Medicine, Immunology, Oncology +14

Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel).

Valérie Vivat‐Hannah, D. You, Christine Rizzo et al. · PubMed · 2001 · 29 citations

Medicine, Oncology, Pharmacology +14

Preclinical <i>In vivo</i> Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models

Sherif Daouti, Brian Higgins, Kenneth Kolinsky et al. · Molecular Cancer Therapeutics · 2010 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Quality Indicators Targeting Low-Value Clinical Practices in Trauma Care

Lynne Moore, Mélanie Berube, Pier‐Alexandre Tardif et al. · JAMA Surgery · 2022 · 20 citations · Full text

Medicine, Emergency Medicine, Healthcare Quality Improvement +13